Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
US2025255088A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025255088-A1 |
| Application number | US-202519187890-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 23, 2025 |
| Priority date | Nov 10, 2022 |
| Publication date | Aug 7, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a heterocyclic compound, an organic light emitting device including the same, and a composition for an organic material layer of the organic light emitting device. The heterocyclic compound may be used as a material for the organic material layer of the organic light emitting device. That is, the heterocyclic compound can serve as a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like in the organic light emitting device. In particular, the heterocyclic compound can be used as a material for a charge generation layer and an electron transport layer of an organic light emitting device.
Opening claim text (preview).
1 . A heterocyclic compound represented by the following Chemical Formula 1: wherein, in Chemical Formula 1, X is O or S, Ar1 is a substituted or unsubstituted C6 to C60 aryl group, Ar2 is a C6 to C60 aryl group substituted with at least one deuterium, R1, R2, Ra, and Rb are the same as or different from each other, and are each independently hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted C1 to C60 alkyl group; a substituted or unsubstituted C6 to C60 aryl group; or a substituted or unsubstituted C2 to C60 heteroaryl group, a1 is an integer from 0 to 3, and when a1 is 2 or higher, substituents in the parenthesis are the same as or different from each other, a2 is an integer from 0 to 3, and when a2 is 2 or higher, substituents in the parenthesis are the same as or different from each other, m is an integer from 0 to 7, and when m is 2 or higher, substituents in the parenthesis are the same as or different from each other, n is an integer from 0 to 7, and when n is 2 or higher, substituents in the parenthesis are the same as or different from each other, and a deuterium substitution rate of of Chemical Formula 1 is 60% to 100%. 2 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by the following Structural Formulae A to C: in Structural Formulae A to C, the definitions of X, Ar1, Ar2, R1, R2, Ra, Rb, a1, a2, m, and n are the same as the definitions in Chemical Formula 1, the deuterium substitution rate of a structure in which Structural Formula A and Structural Formula C are combined is 60% to 100%, and the is a position where Structural Formula A and Structural Formula B are linked, and the is a position where Structural Formula A and Structural Formula C are linked. 3 . The heterocyclic compound of claim 2 , wherein a deuterium substitution rate of Structural Formula B is 0%. 4 . The heterocyclic compound of claim 2 , wherein a deuterium substitution rate of a structure in which Structural Formula A and Structural Formula C are combined is 80% to 100%. 5 . The heterocyclic compound of claim 1 , wherein Ar1 is a C6 to C20 aryl group. 6 . The heterocyclic compound of claim 1 , wherein Ar2 is a C6 to C20 aryl group substituted with at least one deuterium. 7 . The heterocyclic compound of claim 1 , wherein R1, R2, Ra, and Rb are the same as or different from each other, and are each independently hydrogen; or deuterium. 8 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by any one of the following compounds: 9 . An organic light emitting device comprising: a first electrode; a second electrode provided to face the first electrode; and an organic material layer having one or more layers provided between the first electrode and the second electrode, wherein one or more layers of the organic material layer comprise the het
Triplet emission · CPC title
Electron transporting layers · CPC title
comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title
comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes · CPC title
Carrier injection layers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.